According to our latest study on “Veterinary Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis" the market is expected to grow from US$ 4,045.50 million in 2022 and is expected to reach US$ 7,270.43 million by 2030; it is anticipated to record a CAGR of 7.60% from 2022 to 2030. The report highlights the key factors driving the Veterinary Diagnostics market growth and prominent players with their developments in the market.

Veterinary diagnostic solution helps to quickly identify health conditions for a variety of animals such as cattle, pigs, sheep, and goats. Veterinary diagnostics are critical for animal health, identifying health issues before they can be detected and supporting faster diagnosis and treatment planning. Traditional veterinary diagnostics analyzes blood, tissue, urine, or stool to detect proteins, antibodies, disease presence or general indicators of overall health. Lab-based testing ensures accurate quality results while point-of-care diagnostics enable real-time decisions that can ease concerned animal owners.

Based on product, the veterinary diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger market share in 2022. The consumables segment is expected to record a significant CAGR during 2022–2030. Veterinary consumables involve testing tubes, containers, petri dishes, deep well plates, and kits comprising syringes, needles, safety lancets, IV sets & tubes, and samplers. These consumables are intended to be used for companion animal diagnostics, such as pet (canine, feline, and avian), bovine, goat, swine, equine, and poultry.

Based on technology, the global veterinary diagnostics market is segmented as immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment is further segmented as lateral flow assays, ELISA tests, immunoassay analyzers, allergen-specific immunodiagnostic tests, and another immunodiagnostics. Clinical biochemistry segment is further segmented as clinical chemistry analysis, glucose monitoring, blood gas & electrolyte. The immunodiagnostics segment held the larger largest market share in 2022 and the same segment is anticipated to register the higher highest CAGR during the forecast period 2022–2030.

Regarding animal type, the veterinary diagnostics market is bifurcated into livestock and companion animals. The livestock animals is further segmented as cattle, pigs, poultry, and other livestock animals. Companion animals is further segmented as dogs, cats, horses, and other companion animals. The companion animal segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022–2030.

By end user, the market is segmented as veterinary hospitals & clinics, animal diagnostic laboratories, and veterinary research institutes & universities. The veterinary hospitals & clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the veterinary diagnostics market during 2022–2030.

By disease type, the market is categorized into infectious diseases and non-infectious diseases. The infectious disease segment held a larger market share in 2022 and is anticipated to register a higher CAGR in the veterinary diagnostics market during 2022–2030.

Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Zoetis Inc, Heska Corp, Neogen Corp, Randox Laboratories Ltd, Virbac SA, INDICAL BIOSCIENCE GmbH, FUJIFILM Holdings Corp, and Merck Animal Health. are among the leading companies operating in the global Veterinary Diagnostics market.    

Companies operating in the veterinary Diagnostics market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the veterinary Diagnostics market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall veterinary diagnostics market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In January 2023, IDEXX Announced Novel Diagnostic Test for Kidney Injury, Expanding its Veterinary Renal Testing Portfolio. It is used for detecting kidney injury in cats and dogs.
• In April 2023, Mars completed the acquisition of Heska, a global provider of advanced veterinary diagnostic and specialty solutions. Heska is now part of Mars Petcare’s Science & Diagnostics division, enabling broader coverage across diagnostics and technology while accelerating R&D and expanding access to pet healthcare solutions globally.
• In August 2023, Zoetis launched first on-farm mastitis diagnostics. Zoetis has launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic, in several European markets. It uses a simple flow dipstick test to detect Gram-positive mastitis in eight hours, enabling results before the next milking. Because only Gram-positive cases often benefit from treatment with antimicrobials, a farmer or vet can use this information to deliver more targeted therapy and ensure antimicrobial usage is focused only on cows that need it.
• In April 2022, Zoetis Added Artificial Intelligence Blood Smear Testing to Vetscan Imagyst. Vetscan Imagyst is a first-of-its- kind technology with a multitude of applications, including AI fecal analysis, digital cytology image transfer and now AI blood smear helping veterinarians broaden in-clinic diagnostic offerings to provide the best possible care for dogs and cats. The Vetscan Imagyst AI-driven blood smear capability efficiently delivers critical information that will assist veterinarians in making diagnoses of, and guiding treatment decisions for, animals who are sick or those with hematologic abnormalities.
• In February 2021, Fujifilm Launched VXR Veterinary X-Ray Room, a Digital Radiography System Dedicated to Veterinary Imaging. The innovative design of this new X-ray room is targeted for veterinarians who want to transition to high-quality, low-dose X-rays with an affordable, versatile, easy-to-use, and easy-to-install system.
• In March 2022, Randox launched the VeraSTAT and the VeraSTAT-V, both machines adding to a portfolio of point-of-care (POC) diagnostics. The VeraSTAT offers users the next generation of rapid diagnosis in as little as six minutes. In contrast, the VeraSTAT-V has been designed to detect the earliest signs of inflammation in veterinary diagnosis.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com